BVM Capital is a local venture capital firm that invests in life science opportunities from the Pennington Biomedical Research Center, the world's leader in diabetes, nutrition and obesity research.
NuMe Health, a US-based biotech start-up developing products that modify the bacteria that live in the gastrointestinal tract, has raised $1.5m in its series A round from a consortium led by BVM Capital.
BVM Capital is a local venture capital firm that invests in life science opportunities from the Pennington Biomedical Research Center, the world’s leader in diabetes, nutrition and obesity research.
